Key Takeaway: Vanda Pharmaceuticals announced its participation in the 2026 Citizens Life Sciences Conference, scheduled for March 11, 2026. The corporate presentation will take place at 2:15 p.m. Eastern Time and can be accessed live on Vanda's corporate website. Investors are encouraged to register early for the event.
Price reaction · baseline $8.6 (2026-02-26 close) · hit after-hours · 2 other VNDA headline(s) in the window, move may be shared
day 0 close · peak
+3.6%
Market Sentiment Analysis
POSITIVE FACTORS
Vanda Pharmaceuticals is actively participating in a prominent conference.
The corporate presentation will be accessible live, enhancing investor engagement.
Vanda is focused on addressing high unmet medical needs.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis
Full Press Release Details
WASHINGTON,Feb. 26, 2026/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq:VNDA) today announced that the company will participate in the 2026 Citizens Life Sciences Conference in Miami on Wednesday, March 11, 2026. A corporate presentation is scheduled for 2:15 p.m. Eastern Time.
The corporate presentation given at the Citizens Life Sciences Conference may be accessed live on Vanda's corporate website,www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visitwww.vandapharma.comand follow us on X @vandapharma.
Corporate Contact:
Kevin MoranSenior Vice President, Chief Financial Officer and TreasurerVanda Pharmaceuticals Inc.202-734-3400[email protected]
Jim Golden / Jack Kelleher / Dan MooreCollected Strategies[email protected]
Frequently Asked Questions
When is Vanda Pharmaceuticals' presentation at the conference?
The presentation is scheduled for March 11, 2026, at 2:15 p.m. Eastern Time.
How can investors access the presentation?
Investors can access the live presentation on Vanda's corporate website.
What should investors do before the conference?
Investors are advised to register and install necessary software at least 15 minutes early.
How long will the archived conference be available?
The archived conference will be available on Vanda's website for approximately 30 days.